Component processes of detection probability in camera-trap studies: understanding the occurrence of false-negatives

Camera-trap studies in the wild record true-positive data, but data loss from false-negatives (i.e. an animal is present but not recorded) is likely to vary and widely impact data quality. Detection probability is defined as the probability of recording an animal if present in the study area. We propose a framework of sequential processes within detection-a pass, trigger, image registration, and images being of sufficient quality. Using Closed Circuit TV (CCTV) combined with camera-trap arrays we quantified variation in, and drivers of, these processes for three medium sized mammal species. We also compared trigger success of wet and dry otter Lutra lutra, as an example of a semi-aquatic species. Data loss from failed trigger, failed registration and poor capture quality varied between species, camera-trap model and settings, and were affected by different environmental and animal variables. Distance had a negative effect on trigger probability and a positive effect on registration probability. Faster animals had both reduced trigger and registration probabilities. Close passes (1m) frequently did not generate triggers, resulting in over 20% data loss for all species. Our results, linked to the framework describing processes, can inform study design to minimise, or account for data loss during analysis and interpretation

Optimising camera trap data quality at mammal resting places.

A thorough understanding of how camera traps function is essential for ensuring correct set-up and quality of data. We illustrate the challenges through a case study of camera trapping an otter Lutra lutra resting and breeding place. Appropriate survey design, such as using multiple cameras, decreasing the distance between cameraand otter holt entrance, and camera trapping for sufficient duration, is likely to reduce the propensity for false negatives and increase our ability to correctly identify and protect mammal resting places

Optimising camera trap data quality at mammal resting places.

A thorough understanding of how camera traps function is essential for ensuring correct set-up and quality of data. We illustrate the challenges through a case study of camera trapping an otter Lutra lutra resting and breeding place. Appropriate survey design, such as using multiple cameras, decreasing the distance between cameraand otter holt entrance, and camera trapping for sufficient duration, is likely to reduce the propensity for false negatives and increase our ability to correctly identify and protect mammal resting places

Clinical utility of anti-cytosolic 5\u27-nucleotidase 1A antibody in idiopathic inflammatory myopathies

OBJECTIVE: To define the clinicopathologic features and diagnostic utility associated with anti-cytosolic 5\u27-nucleotidase 1A (NT5C1A) antibody seropositivity in idiopathic inflammatory myopathies (IIMs). METHODS: Anti-NT5C1A antibody status was clinically tested between 2014 and 2019 in the Washington University neuromuscular clinical laboratory. Using clinicopathologic information available for 593 patients, we classified them as inclusion body myositis (IBM), dermatomyositis, antisynthetase syndrome, immune-mediated necrotizing myopathy (IMNM), nonspecific myositis, or noninflammatory muscle diseases. RESULTS: Of 593 patients, anti-NT5C1A antibody was found in 159/249 (64%) IBM, 11/53 (21%) dermatomyositis, 7/27 (26%) antisynthetase syndrome, 9/76 (12%) IMNM, 20/84 (24%) nonspecific myositis, and 6/104 (6%) noninflammatory muscle diseases patients. Among patients with IBM, anti-NT5C1A antibody seropositive patients had more cytochrome oxidase-negative fibers compared with anti-NT5C1A antibody seronegative patients. Among 14 IBM patients initially negative for anti-NT5C1A antibody, three patients (21%) converted to positive. Anti-NT5C1A antibody seropositivity did not correlate with malignancy, interstitial lung disease, response to treatments in dermatomyositis, antisynthetase syndrome, and IMNM, or survival in IIMs. INTERPRETATION: Anti-NT5C1A antibody is associated with IBM. However, the seropositivity can also be seen in non-IBM IIMs and it does not correlate with any prognostic factors or survival

COVID-19 in patients undergoing chronic kidney replacement therapy and kidney transplant recipients in Scotland: findings and experience from the Scottish Renal Registry

BackgroundInfection with the severe acute respiratory coronavirus 2 (SARS-CoV-2) has led to a worldwide pandemic with coronavirus disease 2019 (COVID-19), the disease caused by SARS-CoV-2, overwhelming healthcare systems globally. Preliminary reports suggest a high incidence of infection and mortality with SARS-CoV-2 in patients receiving kidney replacement therapy (KRT). The aims of this study are to report characteristics, rates and outcomes of all patients affected by infection with SARS-CoV-2 undergoing KRT in Scotland.MethodsStudy design was an observational cohort study. Data were linked between the Scottish Renal Registry, Health Protection Scotland and the Scottish Intensive Care Society Audit Group national data sets using a unique patient identifier (Community Health Index (CHI)) for each individual by the Public Health and Intelligence unit of Public Health, Scotland. Descriptive statistics and survival analyses were performed.Results During the period 1st March 2020 to 31st May 2020, 110 patients receiving KRT tested positive for SARS-CoV-2 amounting to 2% of the prevalent KRT population. Of those affected, 86 were receiving haemodialysis or peritoneal dialysis and 24 had a renal transplant. Patients who tested positive were older and more likely to reside in more deprived postcodes. Mortality was high at 26.7% in the dialysis patients and 29.2% in the transplant patients. ConclusionThe rate of detected SARS-CoV-2 in people receiving KRT in Scotland was relatively low but with a high mortality for those demonstrating infection. Although impossible to confirm, it appears that the measures taken within dialysis units coupled with the national shielding policy, have been effective in protecting this population from infection. <br/

First circumglobal assessment of Southern Hemisphere humpback whale mitochondrial genetic variation and implications for management

The description of genetic population structure over a species\u27 geographic range can provide insights into its evolutionary history and also support effective management efforts. Assessments for globally distributed species are rare, however, requiring significant international coordination and collaboration. The global distribution of demographically discrete populations for the humpback whale Megaptera novaeangliae is not fully known, hampering the definition of appropriate management units. Here, we present the first circumglobal assessment of mito - chondrial genetic population structure across the species\u27 range in the Southern Hemisphere and Arabian Sea. We combine new and existing data from the mitochondrial (mt)DNA control region that resulted in a 311 bp consensus sequence of the mtDNA control region for 3009 individuals sampled across 14 breeding stocks and subpopulations currently recognized by the International Whaling Commission. We assess genetic diversity and test for genetic differentiation and also estimate the magnitude and directionality of historic matrilineal gene flow between putative populations. Our results indicate that maternally directed site fidelity drives significant genetic population structure between breeding stocks within ocean basins. However, patterns of connectivity differ across the circumpolar range, possibly as a result of differences in the extent of longitudinal movements on feeding areas. The number of population comparisons observed to be significantly differentiated were found to diminish at the subpopulation scale when nucleotide differences were examined, indicating that more complex processes underlie genetic structure at this scale. It is crucial that these complexities and uncertainties are afforded greater consideration in management and regulatory efforts